Evidence map›Paper›PMID 42552526›Full record

ArticleBMC health services research2026

Why condition cash transfers? A multimethod pilot study evaluating the conditioning of cash transfers for tuberculosis treatment.

Rachel Forse, Thanh Thi Nguyen, Andrew J Codlin, Luan Nguyen Quang Vo, Lan Nguyen, Nga Nguyen, Anja M C Wiemers, Lan Anh Hoang, Thang Phuoc Dao, Ha Dang Thi Minh and 8 more

Abstract read
In one paragraph

Article in BMC health services research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Rachel ForseFriends for International TB Relief, Hanoi, Vietnam. rachel.forse@ki.se.ORCID http://orcid.org/0000-0002-0716-3342
Thanh Thi NguyenFriends for International TB Relief, Hanoi, Vietnam.
Andrew J CodlinFriends for International TB Relief, Hanoi, Vietnam.
Luan Nguyen Quang VoFriends for International TB Relief, Hanoi, Vietnam.
Lan NguyenIRD VN, Ho Chi Minh City, Vietnam.
Nga NguyenFriends for International TB Relief, Hanoi, Vietnam.
Anja M C WiemersFriends for International TB Relief, Hanoi, Vietnam.
Lan Anh HoangFriends for International TB Relief, Hanoi, Vietnam.
Thang Phuoc DaoFriends for International TB Relief, Hanoi, Vietnam.
Ha Dang Thi MinhPham Ngoc Thach Hospital, Ho Chi Minh City, Vietnam.
Lan Huu NguyenPham Ngoc Thach Hospital, Ho Chi Minh City, Vietnam.
Hoa Binh NguyenNational Lung Hospital / National TB Program, Hanoi, Vietnam.
Dinh Van LuongNational Lung Hospital / National TB Program, Hanoi, Vietnam.
Nhung Viet NguyenNational Lung Hospital / National TB Program, Hanoi, Vietnam.
Maxine CawsBirat Nepal Medical Trust, Kathmandu, Nepal.
Tom WingfieldDepartment of Global Public Health, Karolinska Institutet, Stockholm, Sweden.
Knut LönnrothDepartment of Global Public Health, Karolinska Institutet, Stockholm, Sweden.
Kristi Sidney-AnnerstedtDepartment of Global Public Health, Karolinska Institutet, Stockholm, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTuberculosis (TB) is the archetypal disease of poverty, driven by social determinants and causing catastrophic costs. A 2023 United Nations General Assembly resolution called for all TB-affected people to receive a social benefits package by 2027. Cash transfers have been shown to improve health outcomes; however, operational evidence on their implementation and effectiveness in reducing catastrophic costs due to TB is limited. This pilot study sought to assess the feasibility of delivering cash transfers to people affected by drug-susceptible TB to inform the design of a future trial.

methodsA longitudinal, non-randomized cohort study was conducted in Ho Chi Minh City, Vietnam. Half of the participants received unconditional cash transfers (UCTs) while the other half received conditional cash transfers (CCTs) after monthly appointment attendance and completion of 85% of scheduled doses. We analyzed pilot data to assess rates of participant enrollment, adherence and retention in the intervention, TB treatment success, and catastrophic cost incurrence. A 22-day time and motion study quantified the distribution of time pilot staff spent administering the cash transfer intervention by cohort.

resultsDelivering cash transfers was feasible, with 60/70 (85.7%) and 60/66 (90.9%) of eligible individuals in the CCT and UCT cohorts agreeing to participate, respectively. Only 12.3% of CCT participants had one or more transfers withheld and 5.8% of the total expected CCTs were withheld. Delivering CCTs in the observation period took twice as much time as UCTs (32.4 hours for 43 CCT participants vs. 16.0 hours for 47 UCT participants). There were no significant differences in TB treatment success rates between the cohorts (91.7% CCT vs. 93.3% UCT). Cash transfers caused catastrophic cost incurrence to decline by 12.9% in the CCT cohort (44.2% to 38.5%) and 26.9% in the UCT cohort (26.8% to 19.6%).

conclusionsCash transfers are a feasible way to mitigate the economic burden of TB in Vietnam. The conditionality assessed was not associated with any quantifiable benefits to TB-affected people, and required more effort to implement. A larger trial utilizing similar methods and outcomes is warranted. Our findings inform the design of a slightly modified approach of cash transfer delivery for the larger trial.

Indexed as

TuberculosisAdultAntitubercular AgentsFeasibility StudiesFemaleHumansLongitudinal StudiesMalePilot ProjectsVietnamAntitubercular AgentsCash transfersConditionalityTreatment adherenceTuberculosisUniversal health coverageVietnam

Identifiers

PMID42552526
PMCPMC13439919

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.